期刊文献+

组蛋白去乙酰化酶6(HDAC6)与肿瘤 被引量:3

下载PDF
导出
摘要 组蛋白的乙酰化和去乙酰化是基因表达过程中重要的调控方式,是转录过程中的关键修饰。近年来研究表明组蛋白去乙酰化酶6(HDAC6)通过去除组蛋白的乙酰基和其他转录调控参与肿瘤发生和进展。在细胞分裂周期中不恰当的去乙酰化及从胞质到胞核的重新分布,都可能引起转录抑制,基因表达异常,诱发肿瘤。HDAC6的抑制剂和其他抗癌药物联合应用将有可能找到一条治疗肿瘤新的途径。本文综述了HDAC6在肿瘤发生发展过程中的最新进展。
作者 李斌 王济明
出处 《临床和实验医学杂志》 2006年第12期2030-2031,共2页 Journal of Clinical and Experimental Medicine
  • 相关文献

参考文献15

  • 1Hayashi S;Yamaguchi Y.Estrogen signaling and prediction of endocrine therapy[J],2005(zk).
  • 2Verdel A;Seigneurin-Berny D;Faure AK.HDAC6-induced premature chromatin compaction in mouse oocytes and fertilised eggs[J],2003(04).
  • 3Hideshima T;Bradner JE;Wong J.Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma[J],2005(24).
  • 4Bali P;Pranpat M;Bradner J.Inhibition of histone deacetylase 6acetylates and disrupts the chaperone function of heat shock protein 90:a novel basis for antileukemia activity of histone deacetylase inhibitors[J],2005(29).
  • 5Hubbert C;Guardiola A;Shao R.HDAC6 is a microtubule-associated deacetylase[J],2002(6887).
  • 6Saji S;Kawakami M;Hayashi S.Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer[J],2005(28).
  • 7Yoshida N;Omoto Y;Inoue A.Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes[J],2004(06).
  • 8Zou H;Wu Y;Navre M.Characterization of the two catalytic domains in histone deacetylase 6[J],2006(01).
  • 9Bertos NR;Gilquin B;Chan GK.Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention[J],2004(46).
  • 10Mahlknecht U;Schnittger S;Landgraf F.Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosome p11.23 by in situ hybridization[J],2001(1-2).

同被引文献50

  • 1李新刚,陈燕,吴青.TSA抑制NB4细胞去乙酰化酶活性并促进细胞周期素激酶抑制剂表达[J].中国药理学通报,2005,21(2):165-168. 被引量:5
  • 2孟玫,姜军梅,尹晓燕,朱菊人,秦成勇,郭晓笋.苯丁酸钠对两种人肝癌细胞抑癌基因表达的影响[J].中国药理学通报,2005,21(11):1406-1407. 被引量:4
  • 3唐丽琴,魏伟.组蛋白去乙酰化酶抑制剂与炎症免疫性疾病[J].中国药理学通报,2007,23(1):1-4. 被引量:5
  • 4Shabason J E,Tofilon P J,Camphausen K.HDAC inhibitors in cancer care[J].Oncol (Williston Park),2010,24(2):180-5.
  • 5Rosato R R,Grant S.Histone deacetylase inhibitors:insights into mechanisms of lethality[J].Expert Opin Ther Targets,2005,9(4):809-24.
  • 6Xu W S,Parmigiani R B,Marks P A.Histone deacetylase inhibitors:molecular mechanisms of action[J].Oncogene,2007,26(37):5541-52.
  • 7Bolden J E,Peart M J,Johnstone R W.Anticancer activities of histone deacetylase inhibitors[J].Nat Rev Drug Discov,2006,5(9):769-84.
  • 8Glaser K B.HDAC inhibitors:clinical update and mechanism-based potential[J].Biochem Pharmacol,2007,74(5):659-71.
  • 9Yasui W,Oue N,Ono S,et al.Histone acetylation and gastrointestinal carcinogenesis[J].Ann N Y Acad Sci,2003,983:220-31.
  • 10Bertrand P.Inside HDAC with HDAC inhibitors[J].Eur J Med Chem,2010,45(6):2095-116.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部